Migraine - FOI Response Register

1. How many patients have been treated with the following drugs in the past 4 months:

•           Atogepant (Aquipta) – any disease                      0

•           Erenumab (Aimovig) - any disease                      3

•           Eptinezumab (Vyepti) – any disease                    0

•           Fremanezumab (Ajovy) - any disease                 3

•           Galcanezumab (Emgality) - any disease             0

•           Rimegepant (Vydura) – any disease                    0

•           Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested for migraine ONLY

2. We are seeking to understand the funding and delivery of Botox and anti-CGRP monoclonal antibody treatments (Ajovy, Aimovig, Emgality, Vyepti, Vydura & Aquipta) for migraine.  Could you please answer the following:

•           Does the trust commission/fund Botox treatment for migraine (Y/N)? Y

•           Does the trust commission/fund anti-CGRP treatments for migraine (Y/N)? Y

•           Does the trust actively provide Botox/anti-CGRP treatments for migraine as opposed to sending patients to another trust (Y/N)? Y   

 In case the trust does not provide these treatments, please provide the name of the trust to which you refer migraine patients for these treatments?

NHS Grampian is our referral service for diagnosis so some patients may be treated in Grampian initially

3. In case the trust actively provides Botox/anti-CGRP treatments for migraine but does not commission/fund them, then please provide the name(s) of the other NHS organisations that commission/fund these treatments at your trust.

NHS Grampian